How long until a TAH program breaks even?

Break-even depends on case volume and fixed readiness costs The model starts with 192 annual implants and a $144M annual facility lease, before unprovided payroll and debt service By Year 3, modeled implant volume reaches 672, which spreads fixed costs better, but reimbursement delays and ICU utilization can still push break-even later

Do I need a hospital to run it?

In practical planning terms, yes, this is typically a hospital-based or medical-center-based program The model assumes cardiac surgeons, heart failure cardiologists, perfusionists, critical care nurses, and device technicians Staffing grows from 23 clinical roles in Year 1 to 64 by Year 5, before adding administrative, billing, compliance, and executive support

What affects Total Artificial Heart Program margins most?

Margins move most with reimbursement, implant volume, device costs, ICU use, and staffing coverage Known direct costs equal 205% of revenue in Year 1 and 152% in Year 5 A $450,000 implant episode can look profitable on paper, but extra ICU days, denials, readmissions, or idle specialist coverage can reduce owner take-home fast

What's the best first financial planning step?

Build a case-volume and reimbursement model before hiring to full capacity Start with 192 annual implants, $450,000 implant episode pricing, $129M first-year revenue, and the $144M facility lease Then add real payroll, payer contracts, debt service, reserve policy, and denial assumptions before estimating any owner distribution

How Much Can a Total Artificial Heart Program Owner Make at $129M?

Name: How Much Can a Total Artificial Heart Program Owner Make at $129M?
Brand: Financial Models Lab
SKU: total-artificial-heart-owner-makes
Availability: InStock

Fully Editable

Instant Download

Professional Design

Pre-Built

No Expertise Is Needed

See included products:

Financial Model iTotal Artificial Heart Program Bundle Financial Model template included in this product.

$149 $109

ADD TO YOUR ORDER

Business Plan iTotal Artificial Heart Program Bundle Business Plan template included in this product.

$79 $59

Pitch Deck iTotal Artificial Heart Program Bundle Pitch Deck template included in this product.

$49 $29

Bonus Strategy Pack iIncludes 9 bonus strategy templates:

$146 $94

YOU SAVE $0 TODAY

30-Day Money-Back Guarantee

Created by a Former CFO

Updated for 2026

One-Time Purchase

Description

Description

Key Takeaways

Volume spreads fixed lease costs and improves team use.
Reimbursement and payer mix drive net revenue and cash.
Device, logistics, and ICU days can crush margin.
Referrals and authorization quality determine usable case flow.

Owner income$8.3M–$64.3M

Net margin64%–81%

Revenue for target pay$12.9M

Business difficultyHard

Want to test your owner take-home?

Owner income calculator

Estimate owner take-home and the target-pay gap from monthly revenue, margin, labor, overhead, reserves, and target pay. Use the Year 1, Year 3, and Year 5 planning cases as the default range.

Monthly revenue

Gross margin

82%

Labor cost

Fixed overhead

Marketing

Debt service

Tax reserve

15%

Reinvestment reserve

Target owner pay

Planning note: This is a researched planning estimate, not guaranteed salary, tax advice, or owner distribution advice.

Need the full pro forma view for the Total Artificial Heart Program?

Yes—this Total Artificial Heart Program Financial Model Template adds the full dashboard, reimbursement, volume, staffing, device and ICU costs, lease, reserves, debt, and owner-income scenarios. It’s the next step after income logic. Open the model.

Full pro forma model highlights

Revenue charts: $129M to $793M
Surgeons: 2 to 6
Cardiologists: 3 to 8
Nurses: 12 to 36

Total Artificial Heart Program Financial Model dashboard summarizing key KPIs, runway/cash and performance with a dynamic dashboard for investor-ready reporting and cash-flow blind spot visibility.

Which Total Artificial Heart Program costs reduce take-home most?

If you’re asking which costs cut take-home most in a How Much To Start A Total Artificial Heart Program? setup, the biggest drag is device and surgical kits: they run at 120% of revenue in Year 1 and still 100% in Year 5. That’s before specialized consumables, referral partner costs, and transport; the known direct cost load is 205% in Year 1 and 152% in Year 5, so the model is underwater unless other economics are much better.

Main cost drains

Device and surgical kits: 120% to 100%
Specialized consumables: 30% to 22%
Referral partner costs: 40% to 20%
Transport and logistics: 15% to 10%

What’s still missing

Payroll is not included
ICU days are not included
Blood products and imaging are missing
Infection care, readmissions, debt service, reserves

How many total artificial heart implants are needed to be profitable?

The Total Artificial Heart Program needs reimbursement to exceed direct case costs plus fixed readiness costs; the provided model uses 192 implants in Year 1, 672 in Year 3, and 1,152 in Year 5 as the operating scale, not a confirmed break-even count. For the plan math behind this, see How Do I Write A Business Plan To Launch Total Artificial Heart Program?, because a $144M annual facility lease makes low volume owner income highly volatile.

Volume targets

Year 1 model: 192 implants
Year 3 model: 672 implants
Year 5 model: 1,152 implants
Lease load: $144M per year

Profit gates

Beat direct case costs
Control cost load from 205% to 152%
Secure payer authorization
Fund payroll, debt, compliance, capacity

Is a Total Artificial Heart Program profitable for an owner?

The Total Artificial Heart Program can be financially feasible inside a larger medical center, but it is much harder as a standalone site. Here’s the quick math: model revenue grows from $129M to $793M over 5 years, and known operating profit before unprovided payroll and reserves rises from about $88M to $658M. That only works if referral depth, transplant alignment, 24/7 clinical coverage, payer contracts, outcomes, and capital reserves all support volume.

Why it can work

$129M to $793M revenue path
$88M to $658M operating profit
Best fit: larger medical center
Needs steady referral and transplant flow

Why standalone is tougher

Readiness costs stay high
Reimbursement can move around
Regulation raises setup burden
Capital barriers limit early scale

Which drivers move owner income most?

Implant Volume

192-1,152

More implants spread fixed costs faster and lift owner take-home the most.

Payer Mix

$450K-$506K

Higher reimbursement per case raises revenue before the program hits labor and facility costs.

Direct Costs

20.5%-15.2%

Lower device, consumable, commission, and logistics load keeps more gross margin per implant.

Staffing Model

23-64 roles

Clinical headcount growth must stay close to volume or wages will eat EBITDA.

Referral Network

4.0%-2.0%

Stronger referral flow reduces paid partner commissions and keeps the pipeline full.

ICU Outcomes

$2.71M

Shorter ICU stays protect capacity and stop annual fixed overhead from diluting margin.

Total Artificial Heart Program Core Six Income Drivers

Annual Implant Volume

Annual implant volume drives fixed-cost absorption—that means spreading the $144M facility lease and ready staffing over more cases. Going from 192 implants in Year 1 to 1,152 in Year 5 can improve margin and owner pay, but only if those implants are authorized, scheduled, and completed without wasting ICU time.

Volume alone does not create profit. Revenue grows only if cardiac surgeon capacity rises from 400% to 800%, because more qualified cases must pass through the same operating room, ICU, and follow-up team. If authorizations fail, ICU days stretch, or readmissions rise, the extra volume can raise costs faster than cash comes in.

Track Qualified Cases

Measure qualified authorized implants, not just referrals. Track monthly implants, authorization rate, ICU length of stay, readmissions, and fixed cost per case. That tells you whether volume is actually lowering overhead per implant and improving cash the owner can draw.

Monthly implants: 192 to 1,152 path
Authorization rate: no approval, no revenue
ICU days: drives nursing cost
Readmissions: can erase margin

Build a base, upside, and stress forecast. If case flow is strong but capacity stays near 400%, the program stays underused; if capacity climbs toward 800% and cases stay clean, fixed costs get spread better and take-home income improves.

Reimbursement And Payer Mix

Reimbursement is the net money you keep per total artificial heart case after payer rules, denials, and collections. Even at the same implant volume, episode pricing moves from $450,000 in Year 1 to $506,479 in Year 5, a lift of $56,479 or about 12.6%. That change hits revenue, gross margin, and owner pay fast.

Payer mix changes cash timing, not just price. Medicare, commercial insurance, and negotiated rates can shift authorization rate, denial rate, and collection lag, so the same case load can produce very different cash reserves. Cardiology, perfusion, nursing, and device technician management revenue also adds income, but only if it is actually authorized and collected.

Track payer mix, not just case count

Build the model around Medicare, commercial insurance, negotiated rates, authorization rate, denial rate, and collection lag. Here’s the quick math: same volume, different mix, different cash. If one payer delays payment or denies more often, the program needs more working capital even when revenue looks stable on paper.

Track net revenue by payer
Separate managed-care and episode income
Measure days to cash
Review denied claims weekly

Never treat modeled reimbursement as guaranteed. If authorization slips or denials rise, owner draw gets squeezed before volume shows the problem. The cleanest control is to forecast cash by payer, then stress test the model for slower collections and lower approved case rates.

Device And Direct Clinical Costs

Direct Device Cost Load

This is the main margin lever per total artificial heart case. In the model, device and surgical kits run 120% of revenue in Year 1 and 100% in Year 5, consumables add 30% to 22%, and referral plus logistics add 55% to 30%; that cost mix decides how much cash is left for fixed overhead and owner pay.

Track cost per case, not just volume. If a case brings in the same fee but kit, consumable, or transport spend rises, contribution margin shrinks fast; the model shows a lift from 795% to 848% before fixed costs when direct load falls, so every point saved here drops straight to profit and draw.

Control Cost Per Case

Build each case around one file: episode revenue, device kit cost, consumables, and referral/logistics. Then compare actual spend to the modeled percentages every month. One line tells you the truth: direct cost per case ÷ case revenue. If that ratio drifts up, owner cash gets squeezed before fixed costs are even paid.

Measure cost by case ID.
Separate kits from consumables.
Audit logistics and referral spend.
Flag any case over target.

Specialist Staffing Model

Specialist Staffing Load

This driver is the cost of keeping a 24/7 total artificial heart team ready before cases arrive. Headcount rises from 2 to 6 cardiac surgeons, 3 to 8 heart failure cardiologists, 4 to 8 perfusionists, 12 to 36 critical care nurses, and 2 to 6 device technicians. Low volume hurts take-home because salaries, benefits, call coverage, billing staff, and device coordination are partly fixed even when case count is thin.

The key pressure point is fixed readiness versus variable case labor. If authorized cases do not fill the schedule, payroll sits ahead of revenue and owner draw gets squeezed. What this estimate hides is the dollar pay rate, so the real test is whether staffed capacity stays high enough to spread coverage costs across enough implants and follow-up care.

Track Readiness, Not Just Headcount

Track FTEs, paid call hours, case volume, and staffed-to-case ratio every month. Build the model with separate lines for salaries, benefits, call coverage, billing, and device coordination, because those costs hit even before the next implant is booked. That is the quick math: more ready staff helps access, but only if volume is there to absorb them.

Match staffing to authorized cases.
Monitor idle coverage hours.
Forecast pay against implant volume.
Separate fixed and case labor.

ICU Length Of Stay And Outcomes

ICU Stay Per Case

ICU length of stay is a margin driver because every extra day adds nursing, supplies, imaging, blood products, and complication costs before the case can clear to the next phase of care. For total artificial heart patients, post-implant management revenue helps, but longer ICU time can still wipe out contribution margin if labor and consumables rise faster than collections.

Here’s the quick math: the program’s critical care nursing load rises from 12 nurses at 600% capacity to 36 nurses at 850% capacity. That means bed-days are expensive, so the owner’s take-home income depends on keeping ICU days tight enough to protect margin and free capacity for more billable cases.

Track ICU Days And Cost Per Stay

Measure average ICU days per implant, nursing hours per patient, and direct ICU cost p er case. Also track imaging, blood products, readmissions, and transplant timing, since each one can push cash out before payment catches up. If ICU days drift up, the program may need more nurses or higher reserve cash, which cuts owner draw.

Use a simple sensitivity check: hold implant volume and reimbursement flat, then test how one extra ICU day changes margin. If the added nursing and supply cost exceeds the post-implant management revenue on that case, the owner earns less even when clinical throughput looks busy. That is the real pressure point.

Referral Network Strength

Referral network strength is how well the program turns cardiology, transplant, emergency department, insurer, and regional hospital relationships into authorized, clinically appropriate cases. It drives implant volume, follow-up visits, and post-implant management, so weak referrals leave readiness costs underused and cut owner profit even when clinical skill is strong.

Track referrals received, authorization rate, conversion to implant, payer mix, and days from referral to approval. Here’s the quick math: more covered cases raise revenue and cash flow, but denials or slow approvals keep surgeons, ICU, and coordination capacity idle, which lowers the owner’s take-home pay.

Measure and Tighten Referral Flow

Build the model by source, not as one lump. Split referrals from cardiologists, transplant centers, emergency departments, insurers, and regional hospitals, then tag each case by payer and approval status. The goal is not more leads; it’s more billable, covered cases that can move to implant and long-term care.

Count referrals by source.
Track approval days.
Watch denial and appeal rates.
Measure implant conversion.
Link follow-ups to each case.

Compare low, base, and high owner-income scenarios

Scenario table

Owner income moves with implant volume, staffing, and reimbursement. Low, base, and high cases show how fixed clinical costs and payer mix shape take-home profit.

Compare low, base, and high income cases for the program.
Scenario	Low CaseLow volume risk	Base CaseStaffing intensity	High CaseReimbursement sensitivity
Launch model	This is the lower earnings path, with Year 1 volume and a tighter spread between revenue and costs.	This is the modeled middle path, with Year 3 scale and steady throughput.	This is the stronger earnings path, with Year 5 scale and the widest operating spread.
Typical setup	Year 1 volume is 192 implants with about $129M revenue, a 795% contribution margin, and about $88M known profit before payroll, debt, taxes, and reserves.	Year 3 volume is 672 implants with about $442M revenue, an 821% contribution margin, and about $349M known profit before payroll, debt, taxes, and reserves.	Year 5 volume reaches 1,152 implants with about $793M revenue, an 848% contribution margin, and about $658M known profit before payroll, debt, taxes, and reserves.
Cost drivers	Low implant volume fixed staffing load referral commissions device and surgical kit costs reimbursement pressure	Steady implant volume larger clinical team referral commissions facility and compliance overhead reimbursement mix	High implant volume bigger nursing bench more surgeon coverage higher compliance load payer mix pressure
Owner income rangeBefore owner reserves	$88MVolume risk	$349MCore plan	$658MUpside case
Best fit	Use this to stress-test cash flow if volumes stay near launch levels and payer collection is slow.	Use this as the working plan for budgets, hiring, and lender talks.	Use this to test upside if capacity, staffing, and reimbursement all hold.

Planning note: These scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.

Frequently Asked Questions

Owner take-home cannot be treated as a guaranteed salary The provided model supports $129M in Year 1 revenue, $793M in Year 5 revenue, and known direct cost loads from 205% down to 152% Actual distributions depend on payroll, debt service, taxes, reinvestment, compliance reserves, and the ownership structure